These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8762465)

  • 21. Leukocytosis might precede in-hospital eclampsia in preeclamptic women who do not receive magnesium sulfate.
    Ozkaya O; Sezik M; Sezik HT; Eyi EG
    J Perinat Med; 2006; 34(5):378-82. PubMed ID: 16965224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
    Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pharmacokinetics of magnesium sulfate in pregnant women with threatened abortion and fetal retardation].
    Peiker G; Müller B; Erdmanm M; Dawczynski H; Greinke C
    Pharmazie; 1987 Aug; 42(8):531-2. PubMed ID: 3432334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of serum magnesium sulfate levels in pregnant women with severe preeclampsia between intravenous and intramuscular magnesium sulfate regimens: a randomized controlled trial.
    Manorot M; Tongsong T; Khettglang T
    J Med Assoc Thai; 1996 Feb; 79(2):76-82. PubMed ID: 8868017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure-Response Modeling and Simulation Study.
    Du L; Wenning LA; Carvalho B; Duley L; Brookfield KF; Witjes H; de Greef R; Lumbiganon P; Titapant V; Kongwattanakul K; Long Q; Sangkomkamhang US; Gülmezoglu AM; Oladapo OT
    J Clin Pharmacol; 2019 Nov; 59(11):1519-1526. PubMed ID: 31157410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats.
    Della Paschoa OE; Mandema JW; Voskuyl RA; Danhof M
    J Pharmacol Exp Ther; 1998 Feb; 284(2):460-6. PubMed ID: 9454785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical properties, pharmacokinetics, and pharmacodynamics of a reformulated microemulsion propofol in rats.
    Lee EH; Lee SH; Park DY; Ki KH; Lee EK; Lee DH; Noh GJ
    Anesthesiology; 2008 Sep; 109(3):436-47. PubMed ID: 18719441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women.
    Brookfield KF; Su F; Elkomy MH; Drover DR; Lyell DJ; Carvalho B
    Am J Obstet Gynecol; 2016 Jun; 214(6):737.e1-9. PubMed ID: 26767791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.
    Zhou H; Jang H; Fleischmann RM; Bouman-Thio E; Xu Z; Marini JC; Pendley C; Jiao Q; Shankar G; Marciniak SJ; Cohen SB; Rahman MU; Baker D; Mascelli MA; Davis HM; Everitt DE
    J Clin Pharmacol; 2007 Mar; 47(3):383-96. PubMed ID: 17322150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium sulfate pharmacokinetics: pregnant Capra hircus model.
    Hankins GD; Snyder RR; Hauth JC; Gilstrap LC; Wians FH; Van Dellen AF
    Am J Perinatol; 1990 Jan; 7(1):49-53. PubMed ID: 2294911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ionized and total magnesium concentration in patients with severe pre-eclampsia-eclampsia undergoing magnesium sulfate therapy.
    Mahajan NN
    J Obstet Gynaecol Res; 2008 Feb; 34(1):126, author reply 128. PubMed ID: 18226146
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of magnesium sulfate on electroencephalographic findings in preeclampsia/eclampsia.
    Morris JA
    Obstet Gynecol; 1985 Jun; 65(6):859-60. PubMed ID: 4000576
    [No Abstract]   [Full Text] [Related]  

  • 35. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum ionized magnesium during magnesium sulfate administration for preterm labor and preeclampsia.
    Yoshida M; Matsuda Y; Akizawa Y; Ono E; Ohta H
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):125-8. PubMed ID: 16337073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnesium sulphate in the prophylaxis and treatment of eclampsia.
    Noor S; Halimi M; Faiz NR; Gull F; Akbar N
    J Ayub Med Coll Abbottabad; 2004; 16(2):50-4. PubMed ID: 15455618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrimination of kinetic models in heteroscedastic parametric estimation of bentazepam following multiple dosing.
    Fernandez Lastra C; Gonzalez Lopez F; Dominguez-Gil A; Mariño EL
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):335-8. PubMed ID: 3209281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia.
    Du L; Wenning L; Migoya E; Xu Y; Carvalho B; Brookfield K; Witjes H; de Greef R; Lumbiganon P; Sangkomkamhang U; Titapant V; Duley L; Long Q; Oladapo OT
    J Clin Pharmacol; 2019 Mar; 59(3):374-385. PubMed ID: 30422321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.